BioSig Technologies, Inc. STEX Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s additional paid-in capital?
- BioSig Technologies, Inc. (STEX) reported additional paid-in capital of $924.8M in Q1 2026.
- How has BioSig Technologies, Inc.'s additional paid-in capital changed year-over-year?
- BioSig Technologies, Inc.'s additional paid-in capital increased by 254.7% year-over-year, from $260.74M to $924.8M.
- What is the long-term trend for BioSig Technologies, Inc.'s additional paid-in capital?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s additional paid-in capital has grown at a 36.2% compound annual growth rate (CAGR), from $181.34M to $850.45M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.